NCT01264354View on ClinicalTrials.gov

An Open Study to Evaluate the Efficacy, Safety of Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

August 31, 2012

Study Completion Date

February 28, 2013

Conditions
Chronic Hepatitis B
Interventions
DRUG

Clevudine 30mg

Clevudine 30mg

DRUG

Clevudine 20mg+Adefovir dipivoxil 10mg

Clevudine 20mg+ Adefovir 10mg

DRUG

Clevudine 20mg

Clevudine 20mg

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Bukwang Pharmaceutical

INDUSTRY

NCT01264354 - An Open Study to Evaluate the Efficacy, Safety of Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B | Biotech Hunter | Biotech Hunter